Inhibrx Biosciences, Inc. (INBX)
89.00
-1.53
(-1.69%)
USD |
NASDAQ |
Oct 13, 09:43
Inhibrx Biosciences Market Cap : 1.309B for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 1.332B |
| October 09, 2026 | 1.397B |
| October 08, 2026 | 1.364B |
| October 07, 2026 | 1.373B |
| October 06, 2026 | 1.374B |
| October 05, 2026 | 1.391B |
| October 02, 2026 | 1.427B |
| October 01, 2026 | 1.440B |
| September 30, 2026 | 1.472B |
| September 29, 2026 | 1.542B |
| September 28, 2026 | 1.496B |
| September 25, 2026 | 1.465B |
| September 24, 2026 | 1.477B |
| September 23, 2026 | 1.476B |
| September 22, 2026 | 1.628B |
| September 21, 2026 | 1.648B |
| September 18, 2026 | 1.608B |
| September 17, 2026 | 1.540B |
| September 16, 2026 | 1.497B |
| September 15, 2026 | 1.553B |
| September 14, 2026 | 1.625B |
| September 11, 2026 | 1.607B |
| September 10, 2026 | 1.639B |
| September 09, 2026 | 1.660B |
| September 08, 2026 | 1.682B |
| Date | Value |
|---|---|
| September 04, 2026 | 1.782B |
| September 03, 2026 | 1.798B |
| September 02, 2026 | 1.838B |
| September 01, 2026 | 1.834B |
| August 31, 2026 | 1.864B |
| August 28, 2026 | 1.815B |
| August 27, 2026 | 1.823B |
| August 26, 2026 | 1.844B |
| August 25, 2026 | 1.805B |
| August 24, 2026 | 1.544B |
| August 21, 2026 | 1.524B |
| August 20, 2026 | 1.458B |
| August 19, 2026 | 1.493B |
| August 18, 2026 | 1.392B |
| August 17, 2026 | 1.353B |
| August 14, 2026 | 1.300B |
| August 13, 2026 | 1.427B |
| August 12, 2026 | 1.447B |
| August 11, 2026 | 1.359B |
| August 10, 2026 | 1.360B |
| August 07, 2026 | 1.295B |
| August 06, 2026 | 1.253B |
| August 05, 2026 | 1.225B |
| August 04, 2026 | 1.220B |
| August 03, 2026 | 1.208B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 306.41M |
| Amgen, Inc. | 223.81B |
| Anika Therapeutics, Inc. | 273.95M |
| BioCryst Pharmaceuticals, Inc. | 2.110B |
| Imunon, Inc. | 4.899M |
Market Cap Related Metrics
| Price | 89.00 |
| Earnings Yield | -9.97% |